Related Experiment Videos
[Maternal serum IgA in intrauterine fetal growth retardation]
Insights
Immunoglobulin A (IgA) levels in maternal serum may help diagnose and monitor intrauterine fetal growth retardation. Different IgA correlations with pregnancy weeks were observed in growth-restricted versus control groups.
Area of Science:
- Immunology
- Maternal-fetal medicine
Context:
- Intrauterine fetal growth retardation (IUGR) poses significant risks to newborns.
- Accurate diagnosis and monitoring of IUGR are crucial for timely intervention.
- Current placental function tests may require additional parameters for improved accuracy.
Purpose:
- To investigate the diagnostic and monitoring significance of serum Immunoglobulin A (IgA) levels in intrauterine fetal growth retardation (IUGR).
- To analyze the correlation between maternal serum IgA levels and gestational age in pregnancies with and without fetal growth restriction.
Summary:
- Maternal serum samples from 14 women with newborns below the 10th birth weight percentile (IUGR group) and 18 controls were analyzed for IgA levels using radial immunodiffusion.
- A negative correlation between serum IgA and pregnancy weeks was found in the IUGR group (r = -0.39), while a positive correlation was observed in the control group (r = 0.26).
- These findings suggest distinct patterns of IgA changes during pregnancy in the context of fetal growth restriction.
Impact:
- Serum IgA estimation could serve as a valuable additional parameter in placental function tests during the third trimester.
- This may lead to improved diagnostic capabilities for IUGR.
- Further research can explore the integration of IgA into clinical assessment protocols for high-risk pregnancies.
Abstract:
The problem was to prove the significance of IgA estimations in maternal serum samples with regard to the diagnosis and the monitoring of intrauterine fetal growth retardation. IgA was estimated in serum samples from two groups of patients. The first was formed from 62 serum samples of 14 primi- and multiparae delivered from new-borns with a birth weight below the 10th centile. The second was the control group. 82 serum samples from 18 gravidae were available. The IgA estimations were carried out by means of single radial immunodiffusion according to Mancini and co-workers. The IgA values of the two groups were different considering that linear regression model was used; negative correlation between IgA and pregnancy weeks in group with retarded new-borns (y = -151,78 X + 7579,8; r = -0,39) and positive correlation of these parameters in control group (y = 73,59 X -429,38; r = 0,26). It could be that IgA is an additional parameter within placental function tests of the 3rd trimester of pregnancy.